Add BrightSurf on Google Email

UTA professor explores healing power of music

Dr. Rhonda Winegar investigates the effectiveness of music therapy in supporting neurological care, including its ability to reduce anxiety and depression in Alzheimer's patients. Her research also highlights its potential to regulate heart rate and blood pressure, as well as improve motor function in individuals with Parkinson's disease.

SourceUniversity of Texas at Arlington·JournalThe Journal for Nurse Practitioners·TypeLiterature review·DateApr 16, 2025

Van Andel Institute to recognize Dr. J. Timothy Greenamyre with 2025 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research

Dr. J. Timothy Greenamyre is awarded the 2025 Jay Van Andel Award for his pioneering research into gene-environment interactions and its improved understanding of Parkinson's development and progression. The award highlights his work on mitochondria, LRRK2, and pesticide exposure risks in Parkinson's disease.

Re-purposing 5-nonyloxytryptamine and epirubicin as polysialic acid mimetics for protection from MPP+-induced cytotoxicity in human neuronal cells

Researchers investigated the neuroregenerative potential of 5-NOT and Epi, discovering they protected SH-SY5Y cells from MPP+ toxicity by regulating key proteins. The findings support 5-NOT as a glycomimetic drug candidate for Parkinson's disease treatment.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateApr 9, 2025

UT Health San Antonio neurologists among first to treat patients with deep brain stimulation that adapts to patients’ symptoms

Researchers at UT Health San Antonio are among the first to use adaptive deep brain stimulation technology that adjusts treatment based on a patient's symptoms. This innovative approach offers improved therapy and symptom optimization for patients with Parkinson's disease, dystonia, epilepsy, and essential tremor conditions.

Enzyme engineering opens door to novel therapies for Parkinson’s, cancers and other hard-to-target protein diseases

Researchers have developed a new strategy to target hard-to-target proteins in human cells by reprogramming proteases to selectively degrade disease-causing proteins. The study demonstrates proof of concept for developing novel therapies for Parkinson's disease, cancers, and other illnesses, using α-Synuclein as a model protein.

SourceScripps Research Institute·JournalProceedings of the National Academy of Sciences·DateMar 25, 2025

Blood test shows promise for early detection of dementia

Researchers have discovered a blood test that can identify patients with a sleep disorder who are most likely to develop Dementia with Lewy Bodies. The blood test analyzes two proteins in the blood associated with Alzheimer's disease and predicted dementia risk in almost 90% of patients, four years before symptoms appeared.

SourceMcGill University·JournalBrain·DateMar 11, 2025

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

The Aligning Science Across Parkinson’s (ASAP) initiative offers funding of up to $6M for research community members to develop sustainable tools for Parkinson’s disease research. The funding supports the development of preclinical models, detection reagents, and modulation agents to accelerate therapeutic research.

Peristaltic pump flow induces amyloid formation

Researchers from Osaka University found that peristaltic pump action promotes amyloid nucleation in supersaturated fluids, including blood and cerebrospinal fluid. High shear stress caused by the pumping motion mechanically breaks supersaturation to induce amyloid formation.

SourceOsaka University·Journalnpj Biosensing·TypeExperimental study·DateFeb 18, 2025

Brain inflammation alters behaviour according to sex

Researchers found that neuroinflammation in the hippocampus significantly alters motivation and behaviour in mice, particularly in females. This study suggests that treatments targeting hippocampal neuroinflammation could help reduce cognitive and behavioural symptoms in diseases such as Alzheimer's and Depression.

SourceUniversity of Technology Sydney·JournalBrain Behavior and Immunity·TypeExperimental study·DateDec 18, 2024

'Dancing the blues away' seen in brain imaging in people with Parkinson disease, new study finds

A new study published in the Journal of Medical Internet Research found that dancing improves both self-reported questionnaires and MRI brain scans in people with Parkinson disease. The study, conducted by York University researchers, showed a cumulative effect of dance classes on depression rates over 8 months.

SourceYork University·JournalJournal of Medical Internet Research·TypeObservational study·DateDec 18, 2024

Worsening heat waves pose unique risks to people living with neurodegenerative disease

Worsening heat waves exacerbate symptoms of neurodegenerative diseases like Parkinson's and dementia due to impaired sweating and blood flow. Doctors can take proactive steps by regularly screening for social isolation, providing resources, and utilizing telemedicine to monitor high-risk patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Neurology·TypeCommentary/editorial·DateDec 17, 2024

Two ERC Consolidator Grants in medicine

Researchers at the University of Bonn are developing an AI foundation model to improve radiology and detect Parkinson's disease earlier. The 'Re-Start PD' project aims to identify the condition before symptoms appear, with potential applications in diagnosis, treatment, and prevention.